N. Abolhassani

Discipline

Psychologie (4)

Type de document

Articles (13)

Co-auteur

Date

Source

Mot-clé

Older people (10) âge (9) Human beings (9) Age (9) Age (9) cohorte (9) Lausanne (8) Women (7) Women (7) Population (6) Population (6) Swiss (5) Utilization (5) Gender (5) risque (4) épidémiologie (4) Epidemiology (4) Longitudinal studies (4) Longitudinal studies (4) Risk (4) Longitudinal method (4) Epidemiology (4) Determinants (4) Change (4) Use (4) temps (durée) (3) thérapie (3) tabagisme (3) sécurité (3) qualité de vie (3)

Documents écrit par N. Abolhassani (13) | parle de N. Abolhassani (0)

Association of clinical and genetic risk factors with management of dyslipidaemia: analysis of repeated cross-sectional studies in the general population of Lausanne, Switzerland.
V. Chekanova et al. (21 févr. 2023)
Major malformations risk following early pregnancy exposure to metformin: a systematic review and meta-analysis.
N. Abolhassani et al.
Slowness as a Predictor of Functional Decline in Older Adults: Comparison of Moberg Picking-Up Test and Walking Speed.
N. Abolhassani et al.
Real-world gait speed estimation, frailty and handgrip strength: a cohort-based study.
A. Soltani et al. (23 sept. 2021)
Polypill eligibility and equivalent intake in a Swiss population-based study.
J. Castioni et al. (25 mars 2021)
Impact of urine and mixed incontinence on long-term care preference: a vignette-survey study of community-dwelling older adults.
N. Carvalho et al. (18 févr. 2020)
Change in quality of life among community-dwelling older adults: population-based longitudinal study.
Y. Henchoz et al.
Quality of life profile in three cohorts of community-dwelling Swiss older people.
N. Abolhassani et al. (2 avr. 2019)
Temporal changes in importance of quality of life domains: a longitudinal study in community-dwelling Swiss older people.
N. Abolhassani et al.
Gender differences regarding opinions on long-term care arrangements: A study of community-dwelling older adults.
N. Carvalho et al. (2019)
Polypharmacy, defined as taking five or more drugs, is inadequate in the cardiovascular setting.
N. Abolhassani et al.
Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study.
J. Castioni et al. (21 déc. 2017)
Determinants of change in polypharmacy status in Switzerland: the population-based CoLaus study.
N. Abolhassani et al.